Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06003101 · ClinicalTrials.gov registry record · Phase 3
Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
A Phase 3 study of Femoro Acetabular Impingement and Chondral Defect, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT06003101 is a Phase 3 study of Femoro Acetabular Impingement and Chondral Defect that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 160 participants, below the 197-participant average among 3 other Femoro Acetabular Impingement trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06003101, a Phase 3 study of Femoro Acetabular Impingement and Chondral Defect, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to assess the effect of PRP/PPP/BMAC application on functional outcomes after hip arthroscopy to address acetabular labral pathologies. The main questions it aims to answer are: 1. Does PRP/PPP/BMAC application improve functional outcomes after hip arthroscopy to address acetabular labral pathologies? 2. Does PRP/PPP/BMAC application reduce the arthritic burden as measured by functional outcomes following hip arthroscopy to address labral pathologies with concomitant PRP/PPP/BMAC application?
Conditions Studied
Interventions
- BIOLOGICAL Bone marrow aspirate concentrate (BMAC)
- PROCEDURE Control
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2023-08-30 |
| Est. Completion | 2045-08-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06003101
The ClinicalTrials.gov registry entry for NCT06003101 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 197-participant average among 3 other Femoro Acetabular Impingement trials with a reported enrollment target (19% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Femoro Acetabular Impingement appearing as the primary indexed condition, and to 2 interventions - of which Bone marrow aspirate concentrate (BMAC) is the first listed.
NCT06003101 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06003101 about?
NCT06003101 is a clinical study titled "Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies". The goal of this clinical trial is to assess the effect of PRP/PPP/BMAC application on functional outcomes after hip arthroscopy to address acetabular labral pathologies. The main questions it aims to answer are: 1. Does PRP/PPP/BMAC application improve functional outcomes after hip arthroscopy to ...
What is the current status of trial NCT06003101?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 160 participants. The study started on 2023-08-30. Estimated completion is 2045-08-30.
What conditions does trial NCT06003101 study?
This clinical trial studies the following conditions: Femoro Acetabular Impingement, Chondral Defect, Acetabular Labrum Tear, Bone Marrow Aspirate Concentrate.
What interventions are being tested in trial NCT06003101?
The interventions under investigation include: Bone marrow aspirate concentrate (BMAC) (BIOLOGICAL), Control (PROCEDURE).
Who is sponsoring clinical trial NCT06003101?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06003101 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Femoro Acetabular Impingement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study
RECRUITING · Phase 4
-
Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear
RECRUITING
-
Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.